“I had treatment last year and I want to give something back.”
A trial looking at a vaccine for breast cancer with HER2 (PRESENT)
This trial looked at a vaccine called Neuvax for breast cancer that has receptors for the HER2 protein and has spread to the
More about this trial
Doctors may test your breast cancer cells to see if they have a receptor for a protein called HER2.
Breast cancers that have a large number of these receptors are called HER2 positive. Doctors can treat
Neuvax is a vaccine. It combines a protein that is similar to the HER2 protein with a drug called
In this trial some people have Neuvax and some people have GM-CSF. The researchers will compare the 2 groups.
The aims of this trial are to find out:
- how well Neuvax works for breast cancer that has spread to the lymph nodes and has low to moderate amounts of HER2 protein
- how safe Neuvax is
Summary of results
We contacted the trial team but there won't be results available for this trial.
How to join a clinical trial
Professor Mary O'Brien
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer